Date: 2025/06/02 - 19:31
A novel treatment, an aldosterone synthase inhibitor, safely and consistently lowered blood pressure in individuals with uncontrolled or resistant hypertension, a global phase 3 trial showed.
Date: 2025/05/18 - 16:31
Semaglutide, available under the brand names Ozempic and Wegovy, may help decrease the risk of major adverse cardiovascular events after just six months of starting the medication, a new study indicates.